2026 Medical Pharmacy Trend Report: Part 2 - Drug Overview
This high-level drug overview analyzes medical pharmacy claims across commercial, Medicare and Medicaid populations.
The 2026 Medical Pharmacy Trend Report: Part 2 – Drug Overview reflects Prime Therapeutics’ long‑standing commitment to delivering trusted, data‑driven perspectives that shape the industry conversation. This high-level drug overview analyzes medical pharmacy claims across commercial, Medicare and Medicaid populations. If you're navigating rising costs, emerging therapies or evolving site-of-care dynamics, this report delivers the clarity you need.
Key report highlights include:
- Trend drivers shaping medical pharmacy spend
- Shifts in utilization and cost across lines of business
- Impacts of ultra-high-cost drugs entering the market
- Insights to help payers make more informed decisions
Our medical pharmacy and data analysis experts gather and translate pharmacy claims data into thought leadership that helps inform and influence our clients’ decision making and reinforces our role as a respected voice in medical pharmacy management. For timely updates, we’re publishing the findings in three parts this year; the full Medical Pharmacy Trend Report is scheduled for publication this fall and will include and build on earlier results with comprehensive medical benefit drug trends and forecasts.
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.
Login Portals
Compliance / Legal
Company
